1Sabatine MS, Morrow DA, Giugliano RP, et al. Implications of upstream glycoprotein Ⅱb/Ⅲa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST- elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) ⅢB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS) -TIMI 18 trial[J]. Circulation, 2004,109 (7) : 874-880.
2Welt FG,Rogers SD,Zhang X,et al. GP Ⅱb/Ⅲa inhibition with eptifibatide lowers levels of soluble CD40L and RANTES after percutaneous coronary intervention [J]. Catheter Cardiovasc Interv,2004,61(2) :185-189.
3Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation[J]. N Engl J Med, 1999,340(6):448- 454.
4Ross R. Atherosclerosis-an inflammatory disease[J]. N Engl J Med, 1999,340(2): 115-126.
6Chew DP,Bhatt DL,Robbins MA, et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention[J]. Circulation, 2001,104 (9) :992-997.
7Mueller C, Buettner HJ, Hodgson JM, et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients[J]. Circulation,2002,105(12) :1412-1415.
8Azar RR,Badaoui MG, Sarkis A, et al. Effects of tirofiban and stains on high-sensitivity C-reactive protein, interleukin-6, and soluble CD40 ligand following percutaneous coronary inteventions in patients with stable coronary artery disease[J].Am J Cardiol,2005,95(2) :236-240.
5Rogers C,WeltF GP,Karnovsky MJ,et al.Monocyte recruitment and neointimal hyperplasia in rabbits.Coupled inhibitory effects of heparin[J].Arterioscler Thromb Vasc Biol,1996,16(10):1312-1318.
6Komatsu R,Ueda M,Naruko T,et al.Neointimal tissue response at sites of coronary stenting in humans:macroscopic,histological,and immunohistochemical analyses[J].Circulation,1998,98(3):224-233.
7Mallat Z,Corbaz A,Scoazec A,et al.Expression of Interleukin-18 in human Atherosclerotic plaques and relation to plaque instability[J].Circulation,2001,104(14):1598-1603.
8Almagor M,Kerem A,Banai S,et al.Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease[J].Am Heart J,2003,145(2):248-253.
